SynthesisCurrent atherosclerosis reports2025
The Association between Vitamin D and Peripheral Arterial Disease and its Value as a Prognostic and Diagnostic Marker A Systematic Review and Meta-Analysis.
Synthesis in Current atherosclerosis reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewVitamin D deficiency is associated with increased cardiovascular morbidity and mortality through pathways that foster atherosclerosis. This review aims to clarify the relationship between serum vitamin D and peripheral artery disease (PAD), while evaluating the prognostic implications and diagnostic utility of vitamin D deficiency in PAD patients. RECENT
findingsPatients with PAD, displayed significantly lower serum vitamin D levels compared to non-PAD individuals, mean difference (MD), - 2.12ng/mL (95%CI:-4.13 to - 0.12). Individuals with vitamin D deficiency (< 20 ng/mL) exhibited a higher prevalence of PAD relative to those with insufficient or sufficient levels, odds ratio (OR), 1.52 (95%CI:1.07-2.18). Unadjusted prognostic factor analysis displayed an increased hazard for PAD occurrence among deficient patients, hazard ratio (HR), 1.04 (95%CI:1.02-1.06), an outcome that failed to retain its statistical significance upon parameter adjustment, adjusted HR, 1.01 (95%CI:0.99-1.03). Diagnostic accuracy analysis displayed the poor performance of the 20ng/mL threshold with pooled sensitivity and specificity of 0.76 (95%CI:0.55-0.90) and 0.34 (95%CI:0.17-0.57). Further analysis identified a negative predictive value (NPV) of 94% for the 19.65ng/mL threshold, indicating a 6% prevalence of PAD above this cutoff. While this review displayed both decreased vitamin D concentrations for PAD patients and an increased prevalence of PAD among patients with vitamin D deficiency, the prognostic effect of vitamin D on the development of PAD remains inconclusive. Despite the poor performance of vitamin D deficiency as a diagnostic marker, the NPV displayed by the analysis further supports the possible association between vitamin D deficiency and PAD.
Indexed as
Identifiers
41196504What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.